Neurons with Cat's Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
11 03 2022
Historique:
received: 08 02 2022
revised: 05 03 2022
accepted: 08 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 30 4 2022
Statut: epublish

Résumé

The distinct neuropathological features of the different α-Synucleinopathies, as well as the diversity of the α-Synuclein (α-Syn) intracellular inclusion bodies observed in post mortem brain sections, are thought to reflect the strain diversity characterizing invasive α-Syn amyloids. However, this "one strain, one disease" view is still hypothetical, and to date, a possible disease-specific contribution of non-amyloid factors has not been ruled out. In Multiple System Atrophy (MSA), the buildup of α-Syn inclusions in oligodendrocytes seems to result from the terminal storage of α-Syn amyloid aggregates first pre-assembled in neurons. This assembly occurs at the level of neuronal cytoplasmic inclusions, and even earlier, within neuronal intranuclear inclusions (NIIs). Intriguingly, α-Syn NIIs are never observed in α-Synucleinopathies other than MSA, suggesting that these inclusions originate (i) from the unique molecular properties of the α-Syn fibril strains encountered in this disease, or alternatively, (ii) from other factors specifically dysregulated in MSA and driving the intranuclear fibrillization of α-Syn. We report the isolation and structural characterization of a synthetic human α-Syn fibril strain uniquely capable of seeding α-Syn fibrillization inside the nuclear compartment. In primary mouse cortical neurons, this strain provokes the buildup of NIIs with a remarkable morphology reminiscent of cat's eye marbles (see video abstract). These α-Syn inclusions form giant patterns made of one, two, or three lentiform beams that span the whole intranuclear volume, pushing apart the chromatin. The input fibrils are no longer detectable inside the NIIs, where they become dominated by the aggregation of endogenous α-Syn. In addition to its phosphorylation at S129, α-Syn forming the NIIs acquires an epitope antibody reactivity profile that indicates its organization into fibrils, and is associated with the classical markers of α-Syn pathology p62 and ubiquitin. NIIs are also observed in vivo after intracerebral injection of the fibril strain in mice. Our data thus show that the ability to seed NIIs is a strain property that is integrally encoded in the fibril supramolecular architecture. Upstream alterations of cellular mechanisms are not required. In contrast to the lentiform TDP-43 NIIs, which are observed in certain frontotemporal dementias and which are conditional upon GRN or VCP mutations, our data support the hypothesis that the presence of α-Syn NIIs in MSA is instead purely amyloid-strain-dependent.

Identifiants

pubmed: 35327628
pii: biom12030436
doi: 10.3390/biom12030436
pmc: PMC8946814
pii:
doi:

Substances chimiques

Amyloid 0
alpha-Synuclein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Références

Neurobiol Dis. 2015 Jul;79:81-99
pubmed: 25937088
J Am Chem Soc. 2010 Nov 3;132(43):15164-6
pubmed: 20932028
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Biomol NMR Assign. 2018 Apr;12(1):195-199
pubmed: 29476328
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20051-6
pubmed: 19892735
Neuron. 2011 Oct 6;72(1):57-71
pubmed: 21982369
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4897-902
pubmed: 10781096
Neurobiol Dis. 2021 Apr;151:105256
pubmed: 33429042
Neurosci Lett. 2004 Jan 9;354(2):99-102
pubmed: 14698448
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982
pubmed: 32075919
Sci Adv. 2020 Oct 2;6(40):
pubmed: 33008896
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
Biomol NMR Assign. 2014 Oct;8(2):395-404
pubmed: 24114178
Elife. 2020 Jul 22;9:
pubmed: 32697196
PLoS One. 2014 Mar 05;9(3):e90659
pubmed: 24599158
Biomolecules. 2021 Jun 23;11(7):
pubmed: 34201558
Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R123-6
pubmed: 14976159
Biopolymers. 1986 Sep;25(9):1751-65
pubmed: 3768484
Neuropharmacology. 2014 Jul;82:132-42
pubmed: 23973294
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010-5
pubmed: 19651612
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
J Biol Chem. 1999 Jul 9;274(28):19509-12
pubmed: 10391881
Biomolecules. 2021 Sep 28;11(10):
pubmed: 34680054
Elife. 2019 Dec 09;8:
pubmed: 31815671
Acta Neuropathol. 1988;75(4):345-53
pubmed: 3364159
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33):
pubmed: 34385323
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Mov Disord. 2014 Jul;29(8):991-8
pubmed: 24352892
Neurosci Lett. 1998 Jun 19;249(2-3):180-2
pubmed: 9682846
Acta Neuropathol Commun. 2019 May 20;7(1):80
pubmed: 31109378
FEBS Open Bio. 2021 Apr;11(4):999-1013
pubmed: 33548114
Stem Cell Reports. 2019 Feb 12;12(2):230-244
pubmed: 30639210
Biochem Soc Trans. 2005 Aug;33(Pt 4):578-81
pubmed: 16042548
Lancet Neurol. 2022 Jan;21(1):10-11
pubmed: 34942122
Biomol NMR Assign. 2012 Apr;6(1):51-5
pubmed: 21744165
Arch Neurol. 2001 Feb;58(2):186-90
pubmed: 11176955
J Mov Disord. 2019 Sep;12(3):139-151
pubmed: 31556259
Nat Protoc. 2014 Sep;9(9):2135-46
pubmed: 25122523
Neuropathol Appl Neurobiol. 2007 Feb;33(1):56-66
pubmed: 17239008
Nat Commun. 2013;4:2575
pubmed: 24108358
J Biol Chem. 2001 Apr 6;276(14):10737-44
pubmed: 11152691
Sci Rep. 2022 Jan 21;12(1):1163
pubmed: 35064139
Nat Struct Mol Biol. 2016 May;23(5):409-15
pubmed: 27018801
Biochemistry. 2003 Jul 22;42(28):8465-71
pubmed: 12859192
Ann N Y Acad Sci. 2000;920:16-27
pubmed: 11193145
Nat Med. 2008 May;14(5):501-3
pubmed: 18391963
Cells. 2020 Oct 29;9(11):
pubmed: 33138150
Nat Commun. 2018 Sep 6;9(1):3609
pubmed: 30190461
Biophys J. 2020 Mar 24;118(6):1301-1320
pubmed: 32059758
Neuropathol Appl Neurobiol. 2004 Oct;30(5):546-54
pubmed: 15488031
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Mol Neurodegener. 2013 May 28;8:17
pubmed: 23714769
Acta Neuropathol Commun. 2019 Dec 30;7(1):221
pubmed: 31888771
J Neuropathol Exp Neurol. 2019 Oct 1;78(10):877-890
pubmed: 31504665
Appl Spectrosc. 2005 Jun;59(6):732-45
pubmed: 16053539
FEBS Lett. 2020 Apr;594(8):1271-1283
pubmed: 31912891
Neuropathol Appl Neurobiol. 2007 Feb;33(1):2-42
pubmed: 17239006
Neurobiol Aging. 2010 Jan;31(1):99-103
pubmed: 18457903
Chem Biol. 1995 Mar;2(3):163-9
pubmed: 9383418
NPJ Parkinsons Dis. 2022 Jan 13;8(1):10
pubmed: 35027576
Nat Chem. 2020 Aug;12(8):705-716
pubmed: 32514159
Nat Med. 2008 May;14(5):504-6
pubmed: 18391962
Neuroreport. 2001 Jul 20;12(10):2085-90
pubmed: 11447312
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8318-23
pubmed: 10880566
Biochemistry. 2005 Jan 11;44(1):361-8
pubmed: 15628878
J Neurol Sci. 1992 Feb;107(2):172-82
pubmed: 1314292
Chem Biol. 1995 Jan;2(1):1-5
pubmed: 9383397
Brain. 2021 Nov 29;144(10):2915-2932
pubmed: 34019093
Nature. 2020 Feb;578(7794):273-277
pubmed: 32025029
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15871-6
pubmed: 16247008
Acta Neuropathol. 2017 Jul;134(1):65-78
pubmed: 28130640
Nat Neurosci. 2020 Jan;23(1):21-31
pubmed: 31792467
Biomol NMR Assign. 2016 Apr;10(1):5-12
pubmed: 26318307
Nature. 2020 Sep;585(7825):464-469
pubmed: 32461689
Biomolecules. 2021 Sep 09;11(9):
pubmed: 34572546
J Am Chem Soc. 2010 Feb 3;132(4):1186-7
pubmed: 20055380
Brain. 2013 Apr;136(Pt 4):1128-38
pubmed: 23466394
Acta Neuropathol. 2020 Aug;140(2):169-181
pubmed: 32535770
Neurosci Lett. 1998 Jul 31;251(3):205-8
pubmed: 9726379
Nat Methods. 2012 Jun 28;9(7):690-6
pubmed: 22743774
Acta Neuropathol. 2020 Jun;139(6):977-1000
pubmed: 32356200

Auteurs

Francesca De Giorgi (F)

Institut des Maladies Neurodégénératives, CNRS, UMR 5293, 33076 Bordeaux, France.
Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33076 Bordeaux, France.

Muhammed Bilal Abdul-Shukkoor (MB)

Institut de Chimie et de Biologie des Membranes et des Nano-objets, CNRS, UMR 5248, Université de Bordeaux, 33600 Pessac, France.
Institut Européen de Chimie et Biologie, Université de Bordeaux, 33600 Pessac, France.

Marianna Kashyrina (M)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, 73100 Lecce, Italy.

Leslie-Ann Largitte (LA)

Institut des Maladies Neurodégénératives, CNRS, UMR 5293, 33076 Bordeaux, France.
Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33076 Bordeaux, France.

Francesco De Nuccio (F)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, 73100 Lecce, Italy.

Brice Kauffmann (B)

Institut Européen de Chimie et Biologie, CNRS, Université de Bordeaux, INSERM, UMS3033/US001, 33600 Pessac, France.

Alons Lends (A)

Institut de Chimie et de Biologie des Membranes et des Nano-objets, CNRS, UMR 5248, Université de Bordeaux, 33600 Pessac, France.
Institut Européen de Chimie et Biologie, Université de Bordeaux, 33600 Pessac, France.

Florent Laferrière (F)

Institut des Maladies Neurodégénératives, CNRS, UMR 5293, 33076 Bordeaux, France.
Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33076 Bordeaux, France.

Sébastien Bonhommeau (S)

Institut des Sciences Moléculaires, CNRS, UMR 5255, Université de Bordeaux, 33400 Talence, France.

Dario Domenico Lofrumento (DD)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, 73100 Lecce, Italy.

Luc Bousset (L)

Laboratory of Neurodegenerative Diseases, Institut François Jacob, MIRCen, CEA, CNRS, 92265 Fontenay-aux-Roses, France.

Erwan Bezard (E)

Institut des Maladies Neurodégénératives, CNRS, UMR 5293, 33076 Bordeaux, France.
Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33076 Bordeaux, France.

Thierry Buffeteau (T)

Institut des Sciences Moléculaires, CNRS, UMR 5255, Université de Bordeaux, 33400 Talence, France.

Antoine Loquet (A)

Institut de Chimie et de Biologie des Membranes et des Nano-objets, CNRS, UMR 5248, Université de Bordeaux, 33600 Pessac, France.
Institut Européen de Chimie et Biologie, Université de Bordeaux, 33600 Pessac, France.

François Ichas (F)

Institut des Maladies Neurodégénératives, CNRS, UMR 5293, 33076 Bordeaux, France.
Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, 33076 Bordeaux, France.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH